Pancreatic Adenocarcinoma: Number of Positive Nodes Allows to Distinguish Several N Categories

Annals of Surgery

Volumn 261, Issue 5, 2015, Pages 961-969

  Strobel, Oliver ^a   Hinz, Ulf ^a,b   Gluth, Alexander ^a,d   Hank, Thomas ^a   Hackert, Thilo ^a   Bergmann, Frank ^c   Werner, Jens ^a,d   Büchler, Markus W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Division of Biostatistics   (United States)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

lymph node involvement; lymph node ratio; number of positive nodes; pancreatic cancer; pancreatoduodenectomy; staging; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; EXAMINED LYMPH NODE; FEMALE; GRADE A DELAYED GASTRIC EMPTYING; HIGH VOLUME HOSPITAL; HUMAN; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PATHOLOGY; POSITIVE LYMPH NODE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH DISEASE; STOMACH EMPTYING; TUMOR DIFFERENTIATION; WOUND INFECTION; ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; FOLLOW UP; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL;

ADENOCARCINOMA; AGED; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84930753109     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000814     Document Type: Article

References (26)

1. American Cancer Society. Cancer Facts & Figures. Atlanta, GA: American Cancer Society; 2010.
2. Werner J, Combs SE, Springfeld C, Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol. 2013; 10: 323-333.
3. Hartwig W, Hackert T, Hinz U, Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg. 2011; 254: 311-319.
4. Edge SB, Byrd DR, Compton CC, AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer-Verlag; 2009.
5. Sobin LH, Gospodarowicz MKWCe,. TNM Classification of Malignant Tumors. 7th ed. Hoboken, NJ: John Wiley & Sons; 2009.
6. Hellan M, Sun CL, Artinyan A, The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer. Pancreas. 2008; 37: 19-24.
7. Schwarz RE, Smith DD,. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol. 2006; 13: 1189-1200.
8. Berger AC, Watson JC, Ross EA, The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2004; 70: 235-240.
9. Sierzega M, Popiela T, Kulig J, The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas. 2006; 33: 240-245.
10. House MG, Gonen M, Jarnagin WR, Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg. 2007; 11: 1549-1555.
11. Tomlinson JS, Jain S, Bentrem DJ, Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg. 2007; 142: 767-723.
12. Pawlik TM, Gleisner AL, Cameron JL, Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007; 141: 610-618.
13. Smith RA, Bosonnet L, Ghaneh P, Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma. Dig Surg. 2008; 25: 226-232.
14. Slidell MB, Chang DC, Cameron JL, Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol. 2008; 15: 165-174.
15. Riediger H, Keck T, Wellner U, The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg. 2009; 13: 1337-1344.
16. Konstantinidis IT, Deshpande V, Zheng H, Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma? J Gastrointest Surg. 2010; 14: 261-267.
17. Murakami Y, Uemura K, Sudo T, Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg. 2010; 211: 196-204.
18. La Torre M, Cavallini M, Ramacciato G, Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis. J Surg Oncol. 2011; 104: 629-633.
19. Showalter TN, Winter KA, Berger AC, The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys. 2011; 81: 1328-1335.
20. Huebner M, Kendrick M, Reid-Lombardo KM, Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg. 2012; 16: 920-926.
21. Opfermann KJ, Wahlquist AE, Garrett-Mayer E, Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data. Am J Clin Oncol. 2014; 37: 112-116.
22. Robinson SM, Rahman A, Haugk B, Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2012; 38: 333-339.
23. Valsangkar NP, Bush DM, Michaelson JS, N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013; 17: 257-266.
24. Esposito I, Kleeff J, Bergmann F, Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008; 15: 1651-1660.
25. Verbeke CS, Leitch D, Menon KV, Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006; 93: 1232-1237.
26. Fernandez-Cruz L, Johnson C, Dervenis C,. Locoregional dissemination and extended lymphadenectomy in pancreatic cancer. Dig Surg. 1999; 16: 313-319.